rs763746492

Variant names:

• chr1-154272769-C-A
• rs763746492
• NM_006118.4:c.46C>A

Your query was ambiguous. Multiple possible variants found:

• chr1-154272769-C-A
• chr1-154272769-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2 BP4

The NM_006118.4(HAX1):​c.46C>A​(p.Pro16Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P16S) has been classified as Uncertain significance.

• Frequency: Genomes: not found (cov: 32)
• Consequence: HAX1 NM_006118.4 missense
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.650

Genes affected

HAX1 (HGNC:16915): (HCLS1 associated protein X-1) The protein encoded by this gene is known to associate with hematopoietic cell-specific Lyn substrate 1, a substrate of Src family tyrosine kinases. It also interacts with the product of the polycystic kidney disease 2 gene, mutations in which are associated with autosomal-dominant polycystic kidney disease, and with the F-actin-binding protein, cortactin. It was earlier thought that this gene product is mainly localized in the mitochondria, however, recent studies indicate it to be localized in the cell body. Mutations in this gene result in autosomal recessive severe congenital neutropenia, also known as Kostmann disease. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

ACMG classification

Verdict is Uncertain_significance. Variant got 1 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (MetaRNN=0.3027413).

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
HAX1	NM_006118.4	c.46C>A	p.Pro16Thr	missense_variant	Exon 1 of 7	ENST00000328703.12	NP_006109.2
HAX1	NM_001018837.2	c.46C>A	p.Pro16Thr	missense_variant	Exon 1 of 7		NP_001018238.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
HAX1	ENST00000328703.12	c.46C>A	p.Pro16Thr	missense_variant	Exon 1 of 7	1	NM_006118.4	ENSP00000329002.7

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 31

GnomAD4 genome Cov.: 32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.11
BayesDel_addAF	Benign	-0.014	T
BayesDel_noAF	Benign	-0.26
CADD	Benign	21
DANN	Uncertain	0.99
DEOGEN2	Uncertain	0.46	T;.;.;.
Eigen	Uncertain	0.29
Eigen_PC	Uncertain	0.32
FATHMM_MKL	Benign	0.60	D
LIST_S2	Benign	0.75	T;T;T;T
M_CAP	Benign	0.033	D
MetaRNN	Benign	0.30	T;T;T;T
MetaSVM	Benign	-0.68	T
MutationAssessor	Uncertain	2.7	M;M;M;.
PrimateAI	Benign	0.41	T
PROVEAN	Uncertain	-2.6	D;D;D;D
REVEL	Benign	0.099
Sift	Benign	0.049	D;T;D;D
Sift4G	Benign	0.20	T;T;T;T
Polyphen		0.95	P;B;P;.
Vest4		0.21
MutPred		0.25		Gain of catalytic residue at P16 (P = 0.0058);Gain of catalytic residue at P16 (P = 0.0058);Gain of catalytic residue at P16 (P = 0.0058);Gain of catalytic residue at P16 (P = 0.0058);
MVP		0.90
MPC		0.64
ClinPred		0.97	D
GERP RS		4.5
RBP_binding_hub_radar		0.0
RBP_regulation_power_radar		1.7
Varity_R		0.42
gMVP		0.13

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs763746492; hg19: chr1-154245245;